1Jones NR.The current and future impact of antimicrobial resistance a mong nosocomail bacterial pathogens[J].Diagn Microbiol Infect Dis,1992;15:35.
2Coffey TJ,Daniels M,Mcdougel LK,et al.Genetic analysis of clinical isolated of Streptococcus pneumoniae with highlevel resistance to expanded-spectrum cephalosporins[J].Antimicrobial Agents Chemother,1995;39(6):1306-1313.
3Yamane A,Nadano H,Asahi Y,et al.Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B of peni-cillin-resisitant Streptococcus pneumoniae[J].Antimicrobial Agent and Chemotherapy,1996;40(5):1257.
4Asahi Y,Takeuchi Y,Ubudata K.Diversity of substitution within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X ephalosporinresistant Streptococcus pneumoniae isolates[J].AntimicrobialAgent and motherapy,1999;43(5):1252.
5Yokoyama K,Doi Y,Yamane K,et al.Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa[J].Lancet,2003;362(9399):1888-1893.
6Leclercq R,Courvalin P.Resistance to macrolides and relatedantibiotics in Streptococcus pneumoniae[J].Antimicrob Agents Chenmother,2002;46(9):2727-2734.
7Van Eldere J,Meekers E,Lagrou K,et al.Macrolide-resistancemechanisms in Streptococcus pneumoniae isolates from Belgium[J].ClinMicrobiol Infect,2005;11(4):332-334.
8Nishijima T,Saito Y,Aoki A,et al.Distribution of melE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics[J].J Antimicrob Chemother,1999;43(5):637-643.
9Nilius AM,Ma Z.Ketolides:the future of the macrolides[J].Curr Opin Pharmacol,2002;2(5):493-500.
